Advanced Research on Cryptococcus and Cryptococcosis

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Fungal Pathogens".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 9030

Special Issue Editors


E-Mail Website1 Website2 Website3
Guest Editor
Laboratory of Parasitology and Medical Mycology, University of Montpellier, 34000 Montpellier, France
Interests: molecular epidemiology; medical mycology; resistance to antifungals; Cryptococcus
Laboratory of Parasitology and Medical Mycology, University of Montpellier, 34000 Montpellier, France
Interests: molecular epidemiology; medical mycology; resistance to antifungals; Cryptococcus

Special Issue Information

Dear Colleagues,

The scope of this Special Issue concerns the C. neoformans/ C. gattii species complex according to a one health approach. Cryptococcal meningitis is a neglected opportunistic disease, caused by yeasts belonging to the Cryptococcus neoformans/C. gattii species complex.

Cryptococcus species have been isolated from several ecological niches, such as soil, pigeon droppings, plants and debris in tree holes. Many new reservoirs are now reported (water, arthropods…). Environmental sampling contributes to a better understanding of the epidemiology of the disease. Many ecological niches have been investigated worldwide in order to elucidate the environmental biotope of these species complex. Finding new biotopes at the origin of the contamination is now essential.

Cryptococcal meningitis is always fatal without treatment and it remains deadly under antifungal treatment in 45% of cases. Fluconazole is the most commonly administered drug for the treatment of cryptococcosis in low-resource countries. Its intensive use in prophylaxis and treatment of many fungal infections leads to an increase in relapse and in the emergence of resistant strains. Studies concerning the resistance of Cryptococcus to fluconazole are of great concern in order to improve patient management. There are not well documented strains of the C. gattii species complex.

The intensive use of pesticides results in environmental contamination and the effects on human or animal environmental pathogens are still largely unknown. The risk of exposure of Cryptococcus exists in the environment and it could have an impact on the sensitivity to clinical antifungals and generate cross-resistance as already demonstrated in Aspergillus fumigatus.

Research on the pathogenesis and virulence mechanisms of Cryptococcus has focused on three main areas: adaptation to the host environment, mechanism of immune evasion and production of virulence factors. The mechanisms by which Cryptococcus modulates the expression of virulence factors are studied but specifically in the C. neoformans species complex, little research has been done on species of the C. gattii complex.

Enhanced genomic surveillance of these yeasts in their native environments is needed in order to understand their molecular epidemiology, ecology, biology and evolution and how these influence the epidemiology and pathophysiology of cryptococcosis.

Prof. Dr. Sébastien Bertout
Dr. Virginie Bellet
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • C. neoformans and C. gattii species complex
  • molecular epidemiology
  • resistance to antifungals
  • biotope
  • virulence factors

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 1372 KiB  
Article
Fluconazole Resistance and Virulence in In Vitro Induced-Fluconazole Resistant Strains and in Clinical Fluconazole Resistant Strain of Cryptococcus deuterogattii
by Sébastien Bertout, Laetitia Laroche, Frédéric Roger, Donika Krasteva, Pascal Drakulovski and Virginie Bellet
Pathogens 2023, 12(6), 758; https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens12060758 - 24 May 2023
Cited by 2 | Viewed by 2118
Abstract
Neuromeningeal cryptococcosis is a life-threatening infection of the central nervous system, caused by encapsulated yeast belonging to the Cryptococcus neoformans and Cryptococcus gattii species complexes. Recent data showed that virulence and antifungal resistance are variable for yeasts belonging to the C. gattii species [...] Read more.
Neuromeningeal cryptococcosis is a life-threatening infection of the central nervous system, caused by encapsulated yeast belonging to the Cryptococcus neoformans and Cryptococcus gattii species complexes. Recent data showed that virulence and antifungal resistance are variable for yeasts belonging to the C. gattii species complex. There is an increase in resistance to fluconazole for yeasts of the C. gattii species complex and the virulence is variable according to the genotype. In the present study, (i) we explored and compared the mechanisms of resistance to fluconazole between C. deuterogattii clinically resistant strains and induced fluconazole-resistant strains by exposure to fluconazole in vitro, and (ii) we studied their virulence in the Galleria mellonella study model. We demonstrated that the fluconazole resistance mechanisms involved were different between clinically resistant strains and induced resistant strains. We also demonstrated that fluconazole-induced resistant strains are less virulent when compared to the original susceptible strains. On the contrary, the clinically resistant strain tested maintains its virulence compared to fluconazole-susceptible strains of the same sequence type. Full article
(This article belongs to the Special Issue Advanced Research on Cryptococcus and Cryptococcosis)
Show Figures

Figure 1

16 pages, 860 KiB  
Article
Exposure of Cryptococcus neoformans to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole
by Pascal Drakulovski, Donika Krasteva, Virginie Bellet, Sylvie Randazzo, Frédéric Roger, Cyrille Pottier and Sébastien Bertout
Pathogens 2023, 12(5), 662; https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens12050662 - 29 Apr 2023
Cited by 4 | Viewed by 1405
Abstract
Background: Cross-resistance to medical azoles by exposure to azole pesticides is well documented for Aspergillus family fungi but is poorly evaluated for other environmental pathogen fungi, particularly for yeasts belonging to the Cryptococcus neoformans/Cryptococcus gattii species complexes. Methods: One thousand C. [...] Read more.
Background: Cross-resistance to medical azoles by exposure to azole pesticides is well documented for Aspergillus family fungi but is poorly evaluated for other environmental pathogen fungi, particularly for yeasts belonging to the Cryptococcus neoformans/Cryptococcus gattii species complexes. Methods: One thousand C. neoformans yeast were exposed to various concentrations of seven different commonly used azole pesticides. Clones surviving exposure were picked randomly, and their minimal inhibitory concentrations (MICs) of fluconazole, voriconazole, posaconazole, itraconazole and isavuconazole were assessed. Results: Depending on the pesticide used for exposure, up to 13.3% of selected Cryptococcus colonies showed a phenotype of resistance to fluconazole, and among them, several showed cross-resistance to another or several other medical azoles. Molecular mechanisms involved in the resistance setups seem to be dependent on ERG11 and AFR1 gene overexpression. Conclusion: Exposure to any of the seven azole pesticides tested is capable of increasing the MIC of fluconazole in C. neoformans, including up to the level of the fluconazole-resistant phenotype, as well as generating cross-resistance to other medical azoles in some cases. Full article
(This article belongs to the Special Issue Advanced Research on Cryptococcus and Cryptococcosis)
Show Figures

Figure 1

14 pages, 4503 KiB  
Article
Pulmonary Fibrosis and Hypereosinophilia in TLR9-/- Mice Infected by Cryptococcus gattii
by Elias Barbosa da Silva-Junior, Israel Diniz-Lima, Amanda Couto Silva, Joyce Cristina Guimarães-de-Oliveira, Alexandre Morrot, Leonardo Freire-de-Lima, Leonardo Marques da Fonseca, Lycia de Brito-Gitirana, Debora Decote-Ricardo, Herbert Leonel de Matos Guedes and Celio Geraldo Freire-de-Lima
Pathogens 2022, 11(9), 987; https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens11090987 - 29 Aug 2022
Cited by 2 | Viewed by 1865
Abstract
Cryptococcus gattii is a worldwide-distributed basidiomycetous yeast that can infect immunocompetent hosts. However, little is known about the mechanisms involved in the disease. The innate immune response is essential to the control of infections by microorganisms. Toll-like receptor 9 (TLR9) is an [...] Read more.
Cryptococcus gattii is a worldwide-distributed basidiomycetous yeast that can infect immunocompetent hosts. However, little is known about the mechanisms involved in the disease. The innate immune response is essential to the control of infections by microorganisms. Toll-like receptor 9 (TLR9) is an innate immune receptor, classically described as a non-methylated DNA recognizer and associated with bacteria, protozoa and opportunistic mycosis infection models. Previously, our group showed that TLR9-/- mice were more susceptible to C. gattii after 21 days of infection. However, some questions about the innate immunity involving TLR9 response against C. gattii remain unknown. In order to investigate the systemic cryptococcal infection, we evaluated C57BL/6 mice and C57BL/6 TLR9-/- after intratracheal infection with 104C. gattii yeasts for 21 days. Our data evidenced that TLR9-/- was more susceptible to C. gattii. TLR9-/- mice had hypereosinophilia in pulmonary mixed cellular infiltrate, severe bronchiolitis and vasculitis and type 2 alveolar cell hyperplasia. In addition, TLR9-/- mice developed severe pulmonary fibrosis and areas with strongly birefringent fibers. Together, our results corroborate the hypothesis that TLR9 is important to support the Th1/Th17 response against C. gattii infection in the murine experimental model. Full article
(This article belongs to the Special Issue Advanced Research on Cryptococcus and Cryptococcosis)
Show Figures

Figure 1

Review

Jump to: Research

12 pages, 1693 KiB  
Review
Elevated Intracranial Pressure in Cryptococcal Meningoencephalitis: Examining Old, New, and Promising Drug Therapies
by Abdulaziz H. Alanazi, Mir S. Adil, Xiaorong Lin, Daniel B. Chastain, Andrés F. Henao-Martínez, Carlos Franco-Paredes and Payaningal R. Somanath
Pathogens 2022, 11(7), 783; https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens11070783 - 10 Jul 2022
Cited by 4 | Viewed by 2938
Abstract
Despite the availability of effective antifungal therapy, cryptococcal meningoencephalitis (CM) remains associated with elevated mortality. The spectrum of symptoms associated with the central nervous system (CNS) cryptococcosis is directly caused by the high fungal burden in the subarachnoid space and the peri-endothelial space [...] Read more.
Despite the availability of effective antifungal therapy, cryptococcal meningoencephalitis (CM) remains associated with elevated mortality. The spectrum of symptoms associated with the central nervous system (CNS) cryptococcosis is directly caused by the high fungal burden in the subarachnoid space and the peri-endothelial space of the CNS vasculature, which results in intracranial hypertension (ICH). Management of intracranial pressure (ICP) through aggressive drainage of cerebrospinal fluid by lumbar puncture is associated with increased survival. Unfortunately, these procedures are invasive and require specialized skills and supplies that are not readily available in resource-limited settings that carry the highest burden of CM. The institution of pharmacologic therapies to reduce the production or increase the resorption of cerebrospinal fluid would likely improve clinical outcomes associated with ICH in patients with CM. Here, we discuss the potential role of multiple pharmacologic drug classes such as diuretics, corticosteroids, and antiepileptic agents used to decrease ICP in various neurological conditions as potential future therapies for CM. Full article
(This article belongs to the Special Issue Advanced Research on Cryptococcus and Cryptococcosis)
Back to TopTop